Loading…
Characterization of PacMetUT1, a recently isolated human prostate cancer cell line
BACKGROUND Existing prostate cancer cell lines have limitations. METHODS Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors. RESULTS We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with...
Saved in:
Published in: | The Prostate 2008-06, Vol.68 (8), p.883-892 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93 |
---|---|
cites | cdi_FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93 |
container_end_page | 892 |
container_issue | 8 |
container_start_page | 883 |
container_title | The Prostate |
container_volume | 68 |
creator | Troyer, D.A. Tang, Y. Bedolla, R. Adhvaryu, S.G. Thompson, I.M. Abboud-Werner, S. Sun, L.-Z. Friedrichs, W.E. deGraffenried, L.A. |
description | BACKGROUND
Existing prostate cancer cell lines have limitations.
METHODS
Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors.
RESULTS
We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with prostate cancer. Compared to existing prostate cancer cell lines, the growth rate of PacMetUT1 xenograft tumors is slower with tumors occurring at injection sites and with metastases to lung and liver. Androgen receptor (AR) was detected in vivo by Western blotting and the cells responded to methyltrienolone (R1881). PacMetUT1 cells are more invasive in Matrigel than DU‐145, PC‐3, and LNCaP cells, and showed greater anchorage‐independent growth in soft agar. The cells do not express prostate specific antigen (PSA) in vitro or in xenografts. However, the green fluorescent protein (GFP) gene was introduced and stably expressed in PacMetUT1 cells, allowing tumor imaging in vivo. Xenograft tumors show epithelial features and are positive for keratin, epithelial membrane antigen, EGF receptor, and E cadherin. In contrast, fibroblast markers vimentin, desmin, and Factor VIII, were negative. Karyotyping showed losses of 6p, 7q, 8p, 18q, and 22q, and gains of 8q and 9q; additional genetic material was observed at 2q and 12p.
CONCLUSION
The PacMetUT1 cell line allows metastases to be assessed using a single animal model. Because of its slower growth, PacMetUT1 more closely mimics the human disease. Studies of tumor progression or metastasis can be conducted over a longer period of time. Prostate 68:883–892, 2008. © 2008 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/pros.20758 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69151148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69151148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93</originalsourceid><addsrcrecordid>eNp9kM1OwzAQhC0EglK48ADIJw6IgNeJE-cIEVAEBcSP4GZt3I0IpAnYqaA8PSktcOO0Wumb2dlhbAvEPgghD15d4_elSJReYj0QaRIIEall1hMyEUEEYbLG1r1_FqLDhVxla6DDGCKQPXaTPaFD25IrP7Etm5o3Bb9GO6T2_g72OHJHluq2mvLSNxW2NOJPkzHWfHa17XZusbbkuKWq4lVZ0wZbKbDytLmYfXZ_cnyXDYKLq9Oz7PAisDJVOtAU4whDCURRhGmRpoWUOh5JqwoBeSFjSCDCQmor8lConCSqROZWk9ZxnoZ9tjP37ZK8Tci3Zlz6WQqsqZl4E6egACLdgbtz0HaRvaPCvLpyjG5qQJhZg2b2i_lusIO3F66TfEyjP3RRWQfAHHgvK5r-Y2Wub65uf0yDuab0LX38atC9mDgJE2UeLk_NUA2PzrPHgcnCLxrFiuo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69151148</pqid></control><display><type>article</type><title>Characterization of PacMetUT1, a recently isolated human prostate cancer cell line</title><source>Wiley</source><creator>Troyer, D.A. ; Tang, Y. ; Bedolla, R. ; Adhvaryu, S.G. ; Thompson, I.M. ; Abboud-Werner, S. ; Sun, L.-Z. ; Friedrichs, W.E. ; deGraffenried, L.A.</creator><creatorcontrib>Troyer, D.A. ; Tang, Y. ; Bedolla, R. ; Adhvaryu, S.G. ; Thompson, I.M. ; Abboud-Werner, S. ; Sun, L.-Z. ; Friedrichs, W.E. ; deGraffenried, L.A.</creatorcontrib><description>BACKGROUND
Existing prostate cancer cell lines have limitations.
METHODS
Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors.
RESULTS
We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with prostate cancer. Compared to existing prostate cancer cell lines, the growth rate of PacMetUT1 xenograft tumors is slower with tumors occurring at injection sites and with metastases to lung and liver. Androgen receptor (AR) was detected in vivo by Western blotting and the cells responded to methyltrienolone (R1881). PacMetUT1 cells are more invasive in Matrigel than DU‐145, PC‐3, and LNCaP cells, and showed greater anchorage‐independent growth in soft agar. The cells do not express prostate specific antigen (PSA) in vitro or in xenografts. However, the green fluorescent protein (GFP) gene was introduced and stably expressed in PacMetUT1 cells, allowing tumor imaging in vivo. Xenograft tumors show epithelial features and are positive for keratin, epithelial membrane antigen, EGF receptor, and E cadherin. In contrast, fibroblast markers vimentin, desmin, and Factor VIII, were negative. Karyotyping showed losses of 6p, 7q, 8p, 18q, and 22q, and gains of 8q and 9q; additional genetic material was observed at 2q and 12p.
CONCLUSION
The PacMetUT1 cell line allows metastases to be assessed using a single animal model. Because of its slower growth, PacMetUT1 more closely mimics the human disease. Studies of tumor progression or metastasis can be conducted over a longer period of time. Prostate 68:883–892, 2008. © 2008 Wiley‐Liss, Inc.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.20758</identifier><identifier>PMID: 18361412</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Cell Line, Tumor ; Cell Proliferation ; Cyclin-Dependent Kinase Inhibitor p21 - metabolism ; Humans ; Immunohistochemistry ; Karyotyping ; Male ; metastasis ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Metastasis ; prostate cancer ; prostate cancer cell lines ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Receptors, Androgen - metabolism ; Transforming Growth Factor beta - pharmacology ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>The Prostate, 2008-06, Vol.68 (8), p.883-892</ispartof><rights>Copyright © 2008 Wiley‐Liss, Inc.</rights><rights>(c) 2008 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93</citedby><cites>FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18361412$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Troyer, D.A.</creatorcontrib><creatorcontrib>Tang, Y.</creatorcontrib><creatorcontrib>Bedolla, R.</creatorcontrib><creatorcontrib>Adhvaryu, S.G.</creatorcontrib><creatorcontrib>Thompson, I.M.</creatorcontrib><creatorcontrib>Abboud-Werner, S.</creatorcontrib><creatorcontrib>Sun, L.-Z.</creatorcontrib><creatorcontrib>Friedrichs, W.E.</creatorcontrib><creatorcontrib>deGraffenried, L.A.</creatorcontrib><title>Characterization of PacMetUT1, a recently isolated human prostate cancer cell line</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>BACKGROUND
Existing prostate cancer cell lines have limitations.
METHODS
Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors.
RESULTS
We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with prostate cancer. Compared to existing prostate cancer cell lines, the growth rate of PacMetUT1 xenograft tumors is slower with tumors occurring at injection sites and with metastases to lung and liver. Androgen receptor (AR) was detected in vivo by Western blotting and the cells responded to methyltrienolone (R1881). PacMetUT1 cells are more invasive in Matrigel than DU‐145, PC‐3, and LNCaP cells, and showed greater anchorage‐independent growth in soft agar. The cells do not express prostate specific antigen (PSA) in vitro or in xenografts. However, the green fluorescent protein (GFP) gene was introduced and stably expressed in PacMetUT1 cells, allowing tumor imaging in vivo. Xenograft tumors show epithelial features and are positive for keratin, epithelial membrane antigen, EGF receptor, and E cadherin. In contrast, fibroblast markers vimentin, desmin, and Factor VIII, were negative. Karyotyping showed losses of 6p, 7q, 8p, 18q, and 22q, and gains of 8q and 9q; additional genetic material was observed at 2q and 12p.
CONCLUSION
The PacMetUT1 cell line allows metastases to be assessed using a single animal model. Because of its slower growth, PacMetUT1 more closely mimics the human disease. Studies of tumor progression or metastasis can be conducted over a longer period of time. Prostate 68:883–892, 2008. © 2008 Wiley‐Liss, Inc.</description><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cyclin-Dependent Kinase Inhibitor p21 - metabolism</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Karyotyping</subject><subject>Male</subject><subject>metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Metastasis</subject><subject>prostate cancer</subject><subject>prostate cancer cell lines</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Receptors, Androgen - metabolism</subject><subject>Transforming Growth Factor beta - pharmacology</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwzAQhC0EglK48ADIJw6IgNeJE-cIEVAEBcSP4GZt3I0IpAnYqaA8PSktcOO0Wumb2dlhbAvEPgghD15d4_elSJReYj0QaRIIEall1hMyEUEEYbLG1r1_FqLDhVxla6DDGCKQPXaTPaFD25IrP7Etm5o3Bb9GO6T2_g72OHJHluq2mvLSNxW2NOJPkzHWfHa17XZusbbkuKWq4lVZ0wZbKbDytLmYfXZ_cnyXDYKLq9Oz7PAisDJVOtAU4whDCURRhGmRpoWUOh5JqwoBeSFjSCDCQmor8lConCSqROZWk9ZxnoZ9tjP37ZK8Tci3Zlz6WQqsqZl4E6egACLdgbtz0HaRvaPCvLpyjG5qQJhZg2b2i_lusIO3F66TfEyjP3RRWQfAHHgvK5r-Y2Wub65uf0yDuab0LX38atC9mDgJE2UeLk_NUA2PzrPHgcnCLxrFiuo</recordid><startdate>20080601</startdate><enddate>20080601</enddate><creator>Troyer, D.A.</creator><creator>Tang, Y.</creator><creator>Bedolla, R.</creator><creator>Adhvaryu, S.G.</creator><creator>Thompson, I.M.</creator><creator>Abboud-Werner, S.</creator><creator>Sun, L.-Z.</creator><creator>Friedrichs, W.E.</creator><creator>deGraffenried, L.A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080601</creationdate><title>Characterization of PacMetUT1, a recently isolated human prostate cancer cell line</title><author>Troyer, D.A. ; Tang, Y. ; Bedolla, R. ; Adhvaryu, S.G. ; Thompson, I.M. ; Abboud-Werner, S. ; Sun, L.-Z. ; Friedrichs, W.E. ; deGraffenried, L.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cyclin-Dependent Kinase Inhibitor p21 - metabolism</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Karyotyping</topic><topic>Male</topic><topic>metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Metastasis</topic><topic>prostate cancer</topic><topic>prostate cancer cell lines</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Receptors, Androgen - metabolism</topic><topic>Transforming Growth Factor beta - pharmacology</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Troyer, D.A.</creatorcontrib><creatorcontrib>Tang, Y.</creatorcontrib><creatorcontrib>Bedolla, R.</creatorcontrib><creatorcontrib>Adhvaryu, S.G.</creatorcontrib><creatorcontrib>Thompson, I.M.</creatorcontrib><creatorcontrib>Abboud-Werner, S.</creatorcontrib><creatorcontrib>Sun, L.-Z.</creatorcontrib><creatorcontrib>Friedrichs, W.E.</creatorcontrib><creatorcontrib>deGraffenried, L.A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Troyer, D.A.</au><au>Tang, Y.</au><au>Bedolla, R.</au><au>Adhvaryu, S.G.</au><au>Thompson, I.M.</au><au>Abboud-Werner, S.</au><au>Sun, L.-Z.</au><au>Friedrichs, W.E.</au><au>deGraffenried, L.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of PacMetUT1, a recently isolated human prostate cancer cell line</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2008-06-01</date><risdate>2008</risdate><volume>68</volume><issue>8</issue><spage>883</spage><epage>892</epage><pages>883-892</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><abstract>BACKGROUND
Existing prostate cancer cell lines have limitations.
METHODS
Cells were characterized using Western blotting, immunohistochemistry, invasion into Matrigel, and by studying xenograft tumors.
RESULTS
We describe a cell line (PacMetUT1) isolated from a lymph node of a 57‐year‐old male with prostate cancer. Compared to existing prostate cancer cell lines, the growth rate of PacMetUT1 xenograft tumors is slower with tumors occurring at injection sites and with metastases to lung and liver. Androgen receptor (AR) was detected in vivo by Western blotting and the cells responded to methyltrienolone (R1881). PacMetUT1 cells are more invasive in Matrigel than DU‐145, PC‐3, and LNCaP cells, and showed greater anchorage‐independent growth in soft agar. The cells do not express prostate specific antigen (PSA) in vitro or in xenografts. However, the green fluorescent protein (GFP) gene was introduced and stably expressed in PacMetUT1 cells, allowing tumor imaging in vivo. Xenograft tumors show epithelial features and are positive for keratin, epithelial membrane antigen, EGF receptor, and E cadherin. In contrast, fibroblast markers vimentin, desmin, and Factor VIII, were negative. Karyotyping showed losses of 6p, 7q, 8p, 18q, and 22q, and gains of 8q and 9q; additional genetic material was observed at 2q and 12p.
CONCLUSION
The PacMetUT1 cell line allows metastases to be assessed using a single animal model. Because of its slower growth, PacMetUT1 more closely mimics the human disease. Studies of tumor progression or metastasis can be conducted over a longer period of time. Prostate 68:883–892, 2008. © 2008 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>18361412</pmid><doi>10.1002/pros.20758</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-4137 |
ispartof | The Prostate, 2008-06, Vol.68 (8), p.883-892 |
issn | 0270-4137 1097-0045 |
language | eng |
recordid | cdi_proquest_miscellaneous_69151148 |
source | Wiley |
subjects | Cell Line, Tumor Cell Proliferation Cyclin-Dependent Kinase Inhibitor p21 - metabolism Humans Immunohistochemistry Karyotyping Male metastasis Middle Aged Neoplasm Invasiveness Neoplasm Metastasis prostate cancer prostate cancer cell lines Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Receptors, Androgen - metabolism Transforming Growth Factor beta - pharmacology Tumor Suppressor Protein p53 - metabolism |
title | Characterization of PacMetUT1, a recently isolated human prostate cancer cell line |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T22%3A16%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20PacMetUT1,%20a%20recently%20isolated%20human%20prostate%20cancer%20cell%20line&rft.jtitle=The%20Prostate&rft.au=Troyer,%20D.A.&rft.date=2008-06-01&rft.volume=68&rft.issue=8&rft.spage=883&rft.epage=892&rft.pages=883-892&rft.issn=0270-4137&rft.eissn=1097-0045&rft_id=info:doi/10.1002/pros.20758&rft_dat=%3Cproquest_cross%3E69151148%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2958-8e6ada321ee44a9f99f2286d2c5f01bf261714af28c0b305be2a572bc8e886b93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69151148&rft_id=info:pmid/18361412&rfr_iscdi=true |